Optimizing Severe Asthma Care

Rancho Mirage, CA US
May 2, 2019

Jonathan Corren, MD

Clinical Associate Professor of Medicine and Pediatrics
Divisions of Clinical Immunology and Allergy
David Geffen School of Medicine at UCLA
Los Angeles, California

Target Audience

This activity was developed for physicians including Eisenhower medical staff along with nurses and ancillary staff.

Learning Objectives

At the end of this presentation, participants should be better able to:

  • Explain how phenotypic, endotypic, and genetic characteristics factor into severe asthma
  • Compare and contrast biologic agents that are currently available or emerging in the treatment of severe asthma
  • Identify patients who may benefit from the use of a biologic agent for severe asthma
  • Employ a stepwise approach to incorporate novel, personalized biologic‐based treatment plans for severe asthma into the real‐world clinical setting
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 CA-BRN
Course opens: 
05/02/2019
Course expires: 
12/31/2019
Event starts: 
05/02/2019 - 12:00pm
Event ends: 
05/02/2019 - 1:00pm
Cost:
$0.00
Rating: 
0
Annenberg Center Health Sciences at Eisenhower
39000 Bob Hope Drive
Rancho Mirage, CA 92270
United States

Available Credit

  • 1.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 CA-BRN

Accreditation Period

Course opens: 
05/02/2019
Course expires: 
12/31/2019

Price

Cost:
$0.00
Please login or register to take this course.